Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity
항중증급성호흡기증후군 코로나바이러스 2 항체 반응의 크기 및 동역학 및 질병 중증도와의 관계
Article
Published on
Journal: Clinical Infectious Diseases: An Official Publicat [Category] Fulltext, MERS, 진단, 치료기술, 치료법, 치료제,
Journal: Clinical Infectious Diseases: An Official Publicat [Category] Fulltext, MERS, 진단, 치료기술, 치료법, 치료제,
[키워드] acute infection
acute infections
acute respiratory syndrome
acute respiratory syndrome coronavirus
Affect
antibody
antibody concentration
Antibody concentrations
antibody kinetics
Antibody Response
antiviral antibodies
antiviral antibody
Convalescent patients
coronavirus
coronavirus 2
coronavirus disease
Coronavirus disease 2019
correlation
Course
COVID-19
detect
Diagnosis
diagnostics
disease
disease course
Disease progression
disease severity
dynamic range
evaluated
Host
host antibody response
Host immune response
identify
IgG
IgG responses
IgM
IgM and IgG
Immunoglobulin
Immunoglobulin G
immunoglobulin M
individual
Infection
initial
intensive care
intensive care unit
interval
Kinetics
magnitude
median
Mild
Mild disease
nucleocapsid protein
Pathogenesis
Patient
pattern
polymerase chain
potential therapeutic targets
promote
Quantitative
real-time polymerase chain reaction
Receptor binding domain
relationship
respiratory
response
robust
SARS-CoV-2
SARS-CoV-2 antibody
sera
Seroconversion
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
significantly higher
specimens
Spike protein
Spike protein receptor binding domain
tested
the disease
the SARS-CoV-2
the spike protein
Therapeutics
time interval
time intervals
Vaccine development
Viral
viral neutralization
viruses
[DOI] 10.1093/cid/ciaa979 PMC 바로가기 [Article Type] Article
[DOI] 10.1093/cid/ciaa979 PMC 바로가기 [Article Type] Article